A Multicenter Study of Crisaborole Use in Pediatric Patients with Atopic Dermatitis in Real-World Setting in Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230421004

Enrollment

Registered

2023-04-21

Start date

2023-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis Atopic dermatitis, Children

Interventions

Pediatric atopic dermatitis with mild to moderate severity

Treatment

Atopic dermatitis patients

Eligibility

Sex/Gender

All

Age

3 Months to 18 Years

Inclusion criteria

Inclusion criteria: 1. Atopic patients, older than 3 months-18 years old, with a baseline Investigator Static Global Assessment (ISGA) score of mild and moderate severity 2. Agree to participate in the study 3. Wash out period: topical treatment >2 weeks, systemic treatment included biologic agents > 4 weeks

Exclusion criteria

Exclusion criteria: Atopic patients with skin infection or immunocompromised patient

Design outcomes

Primary

Measure	Time frame
Severity of AD 4 week ISGA score	—

Secondary

Measure	Time frame
pruritus 4 week pruritus scale	—

Countries

Thailand

Contacts

Public ContactSusheera Chatproedprai

Faculty of Medicine, Chulalongkorn University

susheera.c@chula.ac.th66877727052

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026